Laurus Labs Q2 FY27 net profit jumps 126% to ₹441 crore; revenue up 33% to ₹2,206 crore on strong CDMO and affordable medicines growth. The Hyderabad-based drugmaker reported consolidated net profit of Rs 441 crore, up 126 percent from the year-ago period. Revenue rose 33 percent to Rs 2,206.